Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EPS (Basic): 2009-2024

Historic EPS (Basic) for Innoviva (INVA) over the last 16 years, with Dec 2024 value amounting to $0.37.

  • Innoviva's EPS (Basic) rose 6400.00% to $1.30 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.40, marking a year-over-year increase of 2762.59%. This contributed to the annual value of $0.37 for FY2024, which is 86.55% down from last year.
  • Per Innoviva's latest filing, its EPS (Basic) stood at $0.37 for FY2024, which was up 160.16% from -$0.62 recorded in FY2024.
  • Over the past 5 years, Innoviva's EPS (Basic) peaked at $3.24 during FY2021, and registered a low of -$0.75 during FY2021.
  • Over the past 3 years, Innoviva's median EPS (Basic) value was -$0.05 (recorded in 2022), while the average stood at $0.74.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 46.61% in 2021, then tumbled by 86.55% in 2024.
  • Yearly analysis of 5 years shows Innoviva's EPS (Basic) stood at $2.21 in 2020, then reached -$0.75 in 2021, then spiked by 46.61% to $3.24 in 2021, then surged by 37.76% to -$0.47 in 2022, then declined by 5.25% to $3.07 in 2022, then plummeted by 36.49% to -$0.64 in 2023, then declined by 10.42% to $2.75 in 2023, then grew by 3.85% to -$0.62 in 2024, then plummeted by 86.55% to $0.37 in 2024.